Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-11-20 2020-11-20
Drug Identification Number 02244895 02244895
Brand name IMURAN IMURAN
Common or Proper name Imuran® Injection (azathioprine sodium) Imuran® Injection (azathioprine sodium)
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients AZATHIOPRINE AZATHIOPRINE
Strength(s) 50MG 50MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 vial 1 vial
ATC code L04AX L04AX
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-05-01 2021-05-01
Actual discontinuation date
Remaining supply date 2021-05-01 2021-05-01
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments